Profile data is unavailable for this security.
About the company
Koligo Therapeutics Limited is an Australia-based regenerative medicine company. The Company is focused on the commercialization and development of cell therapies for pancreatic diseases. The Company’s product Kyslecel is made from patient’s own pancreatic islets-the cells that produce insulin in pancreas. Patient’s surgeon removes the diseased pancreas, sends it to Koligo, and it preserves patient’s islets to make Kyslecel.
- Revenue in -- (TTM)--
- Net income in --
- Incorporated2018
- Employees--
- LocationKoligo Therapeutics Ltd126 Phillip Street, Level 5Sydney 2000AustraliaAUS
- Phone+61 29299-9690
- Fax+61 29251-7455
- Websitehttps://www.koligo.net
More ▼
